Low Ovarian Reserve Treatment: Options & PRP Rejuvenation

Receiving a diagnosis of diminished ovarian reserve can feel overwhelming, but understanding your body's biological timeline is the first step toward finding a clear path forward. Modern reproductive medicine offers highly personalized strategies, including advanced regenerative therapies, to help you achieve your dream of parenthood. This comprehensive guide explores the latest advancements in low ovarian reserve treatment, helping you navigate your options with confidence and clarity.

What is Low Ovarian Reserve and How is It Diagnosed?

Diminished ovarian reserve (DOR) refers to a clinical condition where a woman's ovaries contain fewer eggs than expected for her reproductive age. Unlike men, who produce sperm continuously throughout their lives, women are born with a finite number of eggs—approximately one to two million at birth. This pool naturally declines over time, accelerating after the age of 35. When this reserve depletes faster than expected, or reaches a critically low level, it can significantly impact natural fertility and response to assisted reproductive technologies.

To accurately assess a woman's remaining egg supply, fertility specialists rely on a combination of endocrine blood tests and pelvic imaging. These diagnostic tools do not measure the exact number of eggs remaining, but they provide a highly reliable estimate of the ovarian pool and how the ovaries are likely to respond to fertility medications.

Understanding AMH Levels and Antral Follicle Count (AFC)

The two primary benchmarks used to diagnose low ovarian reserve are Anti-Müllerian Hormone (AMH) testing and the Antral Follicle Count (AFC).

• Anti-Müllerian Hormone (AMH) Test: AMH is a hormone produced by the granulosa cells in early-stage, developing ovarian follicles. Because it is secreted continuously by these growing follicles, the level of AMH in the bloodstream serves as a direct proxy for the size of the remaining egg pool. Unlike other reproductive hormones, AMH levels remain relatively stable throughout the menstrual cycle, meaning the blood test can be performed at any time. Generally, an AMH level below 1.0 ng/mL suggests a diminished ovarian reserve, while levels below 0.5 ng/mL indicate a more severely depleted pool.
• Antral Follicle Count (AFC): This diagnostic assessment is performed via a transvaginal ultrasound during the early follicular phase of the menstrual cycle (typically days 2 to 5). During the ultrasound, the specialist counts the visible fluid-filled sacs (antral follicles) measuring 2 to 10 millimeters in both ovaries. These follicles represent the active, treatable pool that could potentially mature during a given cycle. An AFC of fewer than 5 to 7 follicles across both ovaries is typically indicative of low ovarian reserve.

It is crucial to understand that low ovarian reserve primarily impacts egg quantity, not necessarily egg quality. While quantity refers to the number of eggs remaining in the reserve, quality refers to the chromosomal normalcy of those eggs. Egg quality is heavily influenced by chronological age. For example, a 30-year-old woman with a low ovarian reserve may have fewer eggs available, but the eggs she does produce are highly likely to be chromosomally healthy, yielding excellent pregnancy outcomes once retrieved and fertilized.

Why Egg Quantity Matters for Your Conception Journey

In a natural, unassisted menstrual cycle, the brain releases follicle-stimulating hormone (FSH) to recruit a cohort of small follicles. Eventually, one dominant follicle emerges, matures, and releases a single egg during ovulation. When a woman has a robust ovarian reserve, this monthly selection process occurs seamlessly. However, when the reserve is diminished, the pool of available follicles is small, which naturally reduces the statistical probability of a healthy egg maturing and ovulating each month.

When undergoing conventional fertility treatments like In Vitro Fertilization (IVF), egg quantity becomes a critical factor in determining cycle success. During standard IVF, high doses of hormones are administered to stimulate the ovaries to mature as many follicles as possible in a single cycle. A higher yield of retrieved eggs provides embryologists with more opportunities to fertilize, culture, and select the healthiest embryo for transfer.

For women with low ovarian reserve, standard high-dose stimulation protocols often yield only a few mature eggs, or in some cases, the cycle may face cancellation due to a poor ovarian response. This biological reality can make the journey to conception feel incredibly stressful.

Receiving a diagnosis of diminished ovarian reserve often carries a heavy emotional burden. Many women experience feelings of grief, anxiety, or urgency, believing that their window for biological motherhood is rapidly closing. While time is indeed an important factor, a low reserve diagnosis does not mean pregnancy is impossible. Rather, it emphasizes the vital importance of timely, highly targeted medical intervention designed to optimize the quality and development of every single remaining egg.

Conventional Low Ovarian Reserve Treatment Options

While we cannot create new eggs naturally, conventional fertility care focuses on maximizing the potential of the remaining egg pool. Fertility specialists utilize highly customized protocols to support ovulation, improve egg quality, and preserve remaining fertility.

Tailored IVF Protocols for Diminished Ovarian Reserve

Standard, aggressive IVF stimulation is often counterproductive for women with low ovarian reserve. High doses of medications can sometimes shut down or overwhelm the ovaries, leading to poor-quality eggs. Instead, reproductive endocrinologists utilize tailored protocols:

• Microdose Flare Protocols: This protocol utilizes a low dose of a GnRH agonist (such as Lupron) early in the cycle to trigger a natural "flare" of the body's own follicle-stimulating hormone (FSH). This natural boost, combined with low-to-moderate doses of synthetic hormones, helps gently stimulate the remaining follicles to grow in a more synchronized manner.
• Mini-IVF (Minimal Stimulation IVF): Rather than aiming for a high number of eggs, Mini-IVF focuses on quality over quantity. Using oral medications (like clomiphene citrate) combined with very low doses of injectable hormones, this protocol aims to retrieve 2 to 5 high-quality eggs. It reduces the physical toll on the body, lowers medication costs, and often yields healthier embryos for women with low reserves.

In addition to customized IVF protocols, specific dietary supplements are often recommended to support cellular health and mitochondrial function within the remaining eggs.

• Coenzyme Q10 (CoQ10): As eggs age, their cellular energy centers (mitochondria) decline in efficiency. CoQ10, a powerful antioxidant, helps support mitochondrial energy production, which is essential for proper chromosome division during fertilization.
• DHEA (Dehydroepiandrosterone): This mild androgen is naturally produced by the adrenal glands. Clinical studies suggest that DHEA supplementation for 8 to 12 weeks prior to an IVF cycle can help improve the ovarian microenvironment, potentially increasing the number of antral follicles and reducing embryo chromosomal abnormalities.

For women who are not yet ready to conceive but have been diagnosed with a declining reserve, egg freezing (oocyte cryopreservation) offers a way to pause the biological clock. By retrieving and vitrifying eggs at their current quality, women can safeguard their future reproductive options.

When autologous options (using one's own eggs) have been exhausted through multiple unsuccessful IVF cycles, donor egg IVF represents a highly successful alternative. By utilizing eggs from a young, healthy donor, couples can bypass the challenges of low quantity and quality, resulting in exceptionally high pregnancy success rates.

How PRP Ovarian Rejuvenation Works to Restore Function

For women seeking to conceive using their own genetic material, regenerative medicine has introduced a groundbreaking approach: Platelet-Rich Plasma (PRP) ovarian rejuvenation. This innovative therapy aims to revitalize ovarian tissue and stimulate dormant follicles that conventional hormone therapies cannot reach.

Platelet-Rich Plasma is a concentrated solution of autologous platelets suspended in a small amount of blood plasma. Platelets are highly rich in bioactive proteins, cytokines, and growth factors that are naturally responsible for tissue healing, cellular regeneration, and blood vessel formation (angiogenesis). Because the PRP is derived entirely from the patient's own blood, there is virtually zero risk of allergic reaction, rejection, or cross-contamination.

The PRP rejuvenation procedure is minimally invasive and performed on an outpatient basis under light sedation to ensure complete patient comfort. The process involves the following steps:

1. Blood Draw: A small sample of the patient's blood is drawn, similar to a routine laboratory blood test.
2. Centrifugation: The blood sample is placed in a specialized centrifuge machine. This device spins the blood at high speeds to separate its components based on density, isolating and concentrating the platelets to several times their normal baseline level.
3. Injection: Using a specialized transvaginal ultrasound-guided needle—identical to the equipment used during a standard IVF egg retrieval—the fertility specialist precisely injects the concentrated PRP directly into the cortex of both ovaries.

The Science of Growth Factors in Ovarian Tissue

Once injected into the ovarian stroma, the platelets release a cascade of essential growth factors, including Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor-beta (TGF-β), and Epidermal Growth Factor (EGF).

These growth factors work to restore the aging ovarian microenvironment. They promote the formation of new blood vessels, which improves oxygenation and nutrient delivery to the ovarian tissue. Furthermore, research suggests that this regenerative environment can activate "sleeping" or dormant primordial follicles—microscopic, inactive follicles that have remained unresponsive to standard fertility hormones. By stimulating these dormant cells to mature into active antral follicles, PRP therapy aims to increase both the quantity and quality of eggs available for future conception or IVF cycles.

Who is a Candidate for PRP Ovarian Treatment?

PRP ovarian rejuvenation is not a universal solution, but it holds significant promise for specific groups of women who have struggled with traditional fertility protocols.

• Premature Ovarian Insufficiency (POI) & Early Menopause: Women under the age of 40 who have experienced a premature loss of ovarian function, or those in early perimenopause, are prime candidates. For these individuals, PRP can help temporarily restore menstrual cycles and stimulate occasional ovulation, offering a precious window of opportunity to attempt conception.
• Poor Responders in Previous IVF Cycles: Women who have undergone standard IVF stimulation but yielded very few eggs, experienced poor embryo quality, or had their cycles canceled due to lack of response can benefit from PRP as a preparatory treatment.
• Age Considerations: While PRP can support tissue regeneration, chronological age remains a major factor in egg quality. The therapy is typically most effective for women under the age of 45, as the remaining cellular structure within the ovaries is more responsive to regenerative growth factors.
• Detectable Ovarian Tissue: To benefit from PRP, candidates must still have detectable ovarian tissue visible on an ultrasound. The therapy relies on stimulating existing, dormant follicles; if the ovaries have completely fibrosed or shrunk due to advanced post-menopause, there may not be enough target tissue to respond to the growth factors.

PRP Rejuvenation vs. Traditional Fertility Treatments

To help you make an informed decision, it is helpful to compare PRP therapy directly with traditional fertility pathways.

For many women, PRP is not viewed as a replacement for conventional treatments, but rather as a powerful supportive therapy. By undergoing PRP rejuvenation several weeks or months before starting a customized IVF cycle, patients can potentially improve their ovarian response, leading to a higher yield of healthy, mature eggs during retrieval.

Realistic Expectations and Next Steps on Your Journey

While PRP ovarian rejuvenation is a highly promising and exciting advancement in reproductive medicine, it is essential to approach the therapy with realistic expectations. It is not a guaranteed cure for infertility, nor can it entirely reverse the natural biological aging of eggs. Rather, it is a clinical tool designed to optimize your biological potential and give your ovaries the best possible environment to function.

Following the PRP procedure, patients enter a structured monitoring phase. Because it takes approximately 90 to 120 days for a microscopic primordial follicle to mature into a fully developed egg, the effects of PRP are typically assessed over a one-to-three-month period. During this time, your fertility specialist will perform regular blood tests to track changes in AMH and FSH levels, alongside transvaginal ultrasounds to monitor any increase in your Antral Follicle Count (AFC).

Consulting a Fertility Specialist in Chennai

Because every woman's ovarian reserve and reproductive history are entirely unique, a personalized approach is vital. Consulting a dedicated fertility specialist who understands both conventional protocols and advanced regenerative therapies ensures that your treatment plan is tailored precisely to your body's needs.

At Yaal Fertility Centre in Chennai, we combine advanced reproductive science with deeply compassionate, patient-centered care. Led by Dr. Rukkayal Fathima, MRCOG (UK), our medical team specializes in managing complex fertility cases, including diminished ovarian reserve and premature ovarian insufficiency. We utilize state-of-the-art diagnostic testing and customized treatment protocols—ranging from tailored mini-IVF to advanced PRP ovarian rejuvenation—to help you navigate your fertility journey with hope and clinical excellence.

If you are ready to explore your options and understand how modern science can support your family-building goals, we invite you to take the next step.

Book an appointment with Yaal Fertility Centre or call us directly at +91 90257 75110 to schedule a personalized consultation with Dr. Rukkayal Fathima.

Frequently Asked Questions About Low Ovarian Reserve

Can I get pregnant naturally with a low ovarian reserve?

Yes, natural pregnancy is entirely possible with a low ovarian reserve, especially if you are younger and your remaining eggs are of high quality. However, because the monthly probability of conception is statistically lower, it is highly recommended to consult a specialist early to monitor your reserve and discuss proactive options.

How long do the effects of PRP ovarian rejuvenation last?

The regenerative effects of a PRP treatment typically peak between 2 to 6 months post-procedure. Because the ovarian reserve continues its natural decline over time, any subsequent fertility treatments, such as egg retrieval or natural conception attempts, should ideally be planned within this active regenerative window.

Are there any risks or side effects associated with PRP therapy?

Because PRP utilizes your own blood, there is no risk of allergic reaction or tissue rejection. The procedure itself carries minimal risk, similar to a standard egg retrieval. Minor, temporary side effects may include mild pelvic cramping, spotting, or light soreness, which typically resolve within 24 to 48 hours.

How do I know if PRP is better for me than going straight to IVF?

PRP is often recommended as a preparatory step before undergoing an IVF cycle, particularly if you have a history of poor response to stimulation or very low AMH levels. A detailed evaluation of your medical history, age, and hormone levels will help your specialist determine if PRP is a suitable precursor to optimize your IVF outcomes.